TMO实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 03:11):

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide...

Stats
今日成交量	718 098
平均成交量	1.34M
市值	218.76B
EPS	$0 ( 2024-04-24 )
下一个收益日期	( $5.13 ) 2024-07-24
Last Dividend	$0.350 ( 2023-12-14 )
Next Dividend	$0 ( N/A )
P/E	36.78
ATR14	$0.179 (0.03%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Casper Marc N	Buy	10 000	Common Stock
2024-04-29	Casper Marc N	Sell	100	Common Stock
2024-04-29	Casper Marc N	Sell	100	Common Stock
2024-04-30	Casper Marc N	Sell	772	Common Stock
2024-04-29	Casper Marc N	Sell	1 400	Common Stock

INSIDER POWER
-6.45
Last 100 transactions
Buy: 175 738 \| Sell: 195 569

音量相关性

長: 0.31 (neutral)

短: -0.99 (very strong negative)

Signal:(71.336) Possible Trading Opportunity Present (swing)

Thermo Fisher Scientific 相关性

10 最正相关
GOEX	0.806
NUGT	0.806
GDXJ	0.805
SGDJ	0.801

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Thermo Fisher Scientific 相关性 - 货币/商品

-0.33
( neutral )

-0.26
( neutral )

-0.04
( neutral )

-0.19
( neutral )

0.76
( moderate )

0.18
( neutral )

Thermo Fisher Scientific 财务报表

Annual	2023
营收:	$42.86B
毛利润:	$15.22B (35.52 %)
EPS:	$15.53

FY	2023
营收:	$42.86B
毛利润:	$15.22B (35.52 %)
EPS:	$15.53

FY	2022
营收:	$44.92B
毛利润:	$19.50B (43.42 %)
EPS:	$17.73

FY	2021
营收:	$39.21B
毛利润:	$19.64B (50.08 %)
EPS:	$19.62

Financial Reports:

No articles found.

Thermo Fisher Scientific Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.300 (N/A)	$0.300 (N/A)	$0.350 (N/A)	$0.350 (N/A)	$0.350 (N/A)	$0.350 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Thermo Fisher Scientific Dividend Information - Dividend Knight

Dividend Sustainability Score: 9.20 - good (91.98%) | Divividend Growth Potential Score: 6.01 - Stable (20.15%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0430	1993-08-06
Last Dividend	$0.350	2023-12-14
Next Dividend	$0	N/A
Payout Date	2024-01-16
Next Payout Date	N/A
# dividends	52	--
Total Paid Out	$12.89	--
Avg. Dividend % Per Year	0.15%	--
Score	4.36	--
Div. Sustainability Score	9.20
Div.Growth Potential Score	6.01
Div. Directional Score	7.60	--

Next Divdend (Est)
(2024-07-05)

$0.358 Estimate 34.05 %

Dividend Stability

0.68 Above Average

Dividend Score

4.36

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1993	$0.0430	0.31%
1994	$0	0.00%
1995	$0	0.00%
1996	$0.00400	0.01%
1997	$0	0.00%
1998	$0	0.00%
1999	$0	0.00%
2000	$0	0.00%
2001	$3.34	11.50%
2002	$0	0.00%
2003	$0	0.00%
2004	$0	0.00%
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0.540	1.15%
2013	$0.600	0.92%
2014	$0.600	0.55%
2015	$0.600	0.47%
2016	$0.600	0.43%
2017	$0.600	0.42%
2018	$0.680	0.35%
2019	$0.760	0.35%
2020	$0.880	0.27%
2021	$1.040	0.22%
2022	$1.200	0.19%
2023	$1.400	0.25%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
ZTR	Dividend Royal	2024-02-09	Monthly	37	8.35%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.142	1.500	7.16	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0622	1.200	7.93	9.51	[0 - 0.3]
returnOnEquityTTM	0.133	1.500	9.63	10.00	[0.1 - 1]
payoutRatioTTM	0.0896	-1.000	9.10	-9.10	[0 - 1]
currentRatioTTM	1.696	0.800	6.52	5.22	[1 - 3]
quickRatioTTM	1.089	0.800	8.30	6.64	[0.8 - 2.5]
cashRatioTTM	0.395	1.500	8.92	10.00	[0.2 - 2]
debtRatioTTM	0.367	-1.500	3.89	-5.83	[0 - 0.6]
interestCoverageTTM	-102.77	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	23.37	2.00	2.21	4.42	[0 - 30]
freeCashFlowPerShareTTM	19.79	2.00	0.105	0.209	[0 - 20]
debtEquityRatioTTM	0.783	-1.500	6.87	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.401	1.000	6.65	6.65	[0.2 - 0.8]
operatingProfitMarginTTM	0.164	1.000	8.71	8.71	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.251	1.000	9.72	9.72	[0.2 - 2]
assetTurnoverTTM	0.438	0.800	-0.416	-0.333	[0.5 - 2]
Total Score				9.20

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.36	1.000	6.43	0	[1 - 100]
returnOnEquityTTM	0.133	2.50	9.76	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	19.79	2.00	3.40	0.209	[0 - 30]
dividendYielPercentageTTM	0.250	1.500	3.74	0	[0 - 0.4]
operatingCashFlowPerShareTTM	23.37	2.00	2.21	4.42	[0 - 30]
payoutRatioTTM	0.0896	1.500	9.10	-9.10	[0 - 1]
pegRatioTTM	1.043	1.500	6.38	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.210	1.000	7.25	0	[0.1 - 0.5]
Total Score				6.01

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.